Estradiol Decline Before hCG Administration in COH Has a Negative Effect on IVF Outcomes in Patients Without OC Pretreatment

References

• Calhaz-Jorge C, Leal F, Cordeiro I., et al. Pituitary down-regulation in IVF cycles: is it necessary to use strict criteria? J Assist Reprod Genet. 1995;12(9):615–619. doi:10.1007/BF02212585
   PubMed Web of Science ®Google Scholar
• Garnett E, Bruno-Gaston J, Cao J, et al. The importance of estradiol measurement in patients undergoing in vitro fertilization. Clin Chim Acta. 2020;501:60–65. doi:10.1016/j.cca.2019.09.021
   PubMed Web of Science ®Google Scholar
• Lyttle Schumacher BM, Mersereau JE, Steiner AZ. Cycle day, estrogen level, and lead follicle size: analysis of 27,790 in vitro fertilization cycles to determine optimal start criteria for gonadotropin-releasing hormone antagonist. Fertil Steril. 2018;109(4):633–637. doi:10.1016/j.fertnstert.2017.12.021
   PubMed Web of Science ®Google Scholar
• Geng Y, Xun Y, Hu S, et al. GnRH antagonist versus follicular-phase single-dose GnRH agonist protocol in patients of normal ovarian responses during controlled ovarian stimulation. Gynecol Endocrinol. 2019;35(4):309–313. doi:10.1080/09513590.2018.1528221
   PubMed Web of Science ®Google Scholar
• Garcia-Velasco JA, Isaza V, Quea G, et al. Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing? Fertil Steril. Mar. 2006;85(3):547–554.
   Google Scholar
• Sun B, Ma Y, Li L, et al. Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI. Front Endocrinol. 2020;11:615957. doi:10.3389/fendo.2020.615957
   PubMed Web of Science ®Google Scholar
• Jones HW, Acosta A, Andrews MC, et al. The importance of the follicular phase to success and failure in in vitro fertilization. Fertil Steril. 1983;40(3):317–321. doi:10.1016/S0015-0282(16)47293-6
   PubMed Web of Science ®Google Scholar
• Styer AK, Jackson KV, Hornstein MD, et al. Pregnancy outcomes in in vitro fertilization cycles with serum estradiol drop prior to human chorionic gonadotropin. Int J Gynaecol Obstet. 2005;89(2):133–137. doi:10.1016/j.ijgo.2005.02.005
   PubMed Web of Science ®Google Scholar
• Fisher S, Grin A, Paltoo A, et al. Falling estradiol levels as a result of intentional reduction in gonadotrophin dose are not associated with poor IVF outcomes, whereas spontaneously falling estradiol levels result in low clinical pregnancy rates. Hum Reprod. 2005;20(1):84–88. doi:10.1093/humrep/deh543
   PubMed Web of Science ®Google Scholar
• Fragouli E, Alfarawati S, Spath K, et al. Morphological and cytogenetic assessment of cleavage and blastocyst stage embryos. Mol Hum Reprod. 2014;20(2):117–126. doi:10.1093/molehr/gat073
   PubMed Web of Science ®Google Scholar
• Gardner DK, Lane M, Stevens J, et al. Reprint of: blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2019;112(4 Suppl1):e81–e84. doi:10.1016/j.fertnstert.2019.08.077
   PubMed Web of Science ®Google Scholar
• Kwan I, Bhattacharya S, Woolner A. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI). Cochrane Database Syst Rev. 2021;4(4):CD005289. doi:10.1002/14651858.CD005289.pub4
   PubMedGoogle Scholar
• Zhang Y, Xu Y, Wang Y, et al. Comparison of the predictive value of progesterone-related indicators for pregnancy outcomes of women undergoing the short-acting GnRH agonist long protocol: a retrospective study. J Ovarian Res. 2021;14(1):14. doi:10.1186/s13048-021-00768-2
   PubMed Web of Science ®Google Scholar
• Shoham Z, Schachter M, Schachter M. Estrogen biosynthesis--regulation, action, remote effects, and value of monitoring in ovarian stimulation cycles. Fertil Steril. 1996;65(4):687–701. doi:10.1016/S0015-0282(16)58197-7
   PubMed Web of Science ®Google Scholar
• Adashi EY, Hsueh AJ. Estrogens augment the stimulation of ovarian aromatase activity by follicle-stimulating hormone in cultured rat granulosa cells. J Biol Chem. 1982;257(11):6077–6083. doi:10.1016/S0021-9258(20)65107-9
   PubMed Web of Science ®Google Scholar
• McNatty KP, Smith DM, Makris A, et al. The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab. 1979;49(6):851–860. doi:10.1210/jcem-49-6-851
   PubMed Web of Science ®Google Scholar
• Hillier SG, Reichert LE, Van Hall EV. Control of preovulatory follicular estrogen biosynthesis in the human ovary. J Clin Endocrinol Metab. 1981;52(5):847–856. doi:10.1210/jcem-52-5-847
   PubMed Web of Science ®Google Scholar
• Billig H, Furuta I, Hsueh AJ. Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology. 1993;133(5):2204–2212. doi:10.1210/endo.133.5.8404672
   PubMed Web of Science ®Google Scholar
• Xu L, Ding L, Jiang J, et al. Effects of oral contraceptive pretreatment on IVF outcomes in women following a GnRH agonist protocol. Reprod Biomed Online. 2019;39(6):924–930. doi:10.1016/j.rbmo.2019.08.002
   PubMed Web of Science ®Google Scholar
• Nassar J, Tadros T, Adda-Herzog E, et al. Steroid hormone pretreatments in assisted reproductive technology. Fertil Steril. 2016;106(7):1608–1614. doi:10.1016/j.fertnstert.2016.09.013
   PubMed Web of Science ®Google Scholar
• Wei D, Shi Y, Li J, et al. Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome. Hum Reprod. 2017;32(2):354–361. doi:10.1093/humrep/dew325
   PubMed Web of Science ®Google Scholar
• Kolibianakis EM, Papanikolaou EG, Camus M, et al. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod. 2006;21(2):352–357. doi:10.1093/humrep/dei348
   PubMed Web of Science ®Google Scholar
• Meldrum DR, Scott RT, Levy MJ, et al. Oral contraceptive pretreatment in women undergoing controlled ovarian stimulation in ganirelix acetate cycles may, for a subset of patients, be associated with low serum luteinizing hormone levels, reduced ovarian response to gonadotropins, and early pregnancy loss. Fertil Steril. 2009;91(5):1963–1965. doi:10.1016/j.fertnstert.2008.01.007
   PubMed Web of Science ®Google Scholar
• Medenica S, Zivanovic D, Batkoska L, et al. The future is coming: artificial intelligence in the treatment of infertility could improve assisted reproduction outcomes-the value of regulatory frameworks. Diagnostics. 2022;12(12):2979. doi:10.3390/diagnostics12122979
   Web of Science ®Google Scholar